HealthyLiving
Meeting category
Date(s)
19 Nov 2020 - 20 Nov 2020
Meeting type
Virtual Meeting
EACCME Credits
5
Organizer

Workshop on Healthy Living with HIV 2020

Related Enduring Materials

Enduring Materials

Day 1 - Thursday, 19 November 2020

- 15:00
15:00 CET
Welcome, Introductions and Goals: Guidance on Using Online Format and Online Needs Assessment
Jonathan Schapiro, MD
National Hemophilia Center, Sheba Medical Center, Israel
Session 1: E-Medicine: State of the Art and Future Challenges - 15:04
15:04 CET
State of the Art Lecture: The Role of E-Health on the Future of Health Care
Nicky Hekster
Nicky Hekster, PhD
IBM Watson Health
15:18 CET
Roundtable Discussion: Technology and Medicine Experts
15:20 CET
The Liverpool Website and App
David Back, PhD
University of Liverpool, United Kingdom
15:27 CET
Stanford Database
Robert Shafer, MD
Stanford University, United States
15:36 CET
56DS
Gary Whitlock, MD
56 Dean Street Clinic, Chelsea & Westminster Hospital, United Kingdom
15:42 CET
EmERGE Project
Jenny Whetham
Jenny Whetham, MD
Brighton and Sussex University Hospital NHS Trust, United Kingdom
15:49 CET
UK/US Technology Expert on Different E-Medicine System
Mohammad
Mohammad Al-Ubaydli, MD
Patients Know Best, United Kingdom
15:55 CET
Live Q/A
16:09 CET
Closing
Pozniak
Anton Pozniak, MD, FRCP
Chelsea and Westminster Hospital, United Kingdom
Session 2: Patient-Related Outcomes (PROMS) - 16:27
16:27 CET
PROMs: Which really matter, how to determine them?
Richard Harding
Richard Harding, PhD
King's College London, United Kingdom
16:42 CET
PROMS and HIV
Diana Barger
Diana Barger, MD, PhD
Université de Bordeaux, France
16:59 CET
Ethnic, gender and cultural considerations in PROMs and their significance
Giulio M. Corbelli
Giulio Maria Corbelli
European Community Advisory Board, Italy
17:14 CET
Live Q/A
17:30 CET
Abstract Driven Presentation Session
Tele-counseling Helps Maintain Employee Productivity and Patient Reach in the Context of the COVID-19 Pandemic for HIV Patients from Baylor Black Sea Foundation (BBSF), Romania. #O_02
Elena Rizea, Baylor Black Sea Foundation, Romania
Meet Marvin, the Chatbot: Using Artificial Intelligence to Engage HIV Patients in their Antiretroviral Therapy. #O_03
Yuanchao MA, Research Institute - McGill University Health Centre, Canada
17:43 CET
Live Q&A
Session 3: Adherence to Therapy - 18:06
18:06 CET
PROMS and adherence
Kim Engler
Kim Engler, PhD
McGill University Health Centre, Canada
18:22 CET
Improved adherence with non-PO medications: What are the data?
Susan Swindells
Susan Swindells, MBBS
University of Nebraska Medical Center, USA
18:38 CET
Adherence in 2030 – What will HIV infected patients be taking?
Bonaventura Clotet
Bonaventura Clotet, MD, PhD
Hospital Universitari " Germans Trias I Pujol", Spain
18:53 CET
Live Q/A
19:09 CET
Poster Viewing Session

Day 2 - Friday, 20 November 2020

Session 4: Lifestyle and HIV - 15:03
15:03 CET
Interventions for healthier living in HIV infected patients: What are the data?
François Venter, MD, FCP, PhD
Ezintsha, University of the Witwatersrand, South Africa
15:19 CET
State of the Art Lecture: Strategies to improve metabolic risk factors in HIV infected patients
Andrew Carr, MD, MBBS
St Vincent’s Hospital, Australia
15:37 CET
State of the Art Lecture: Long term prevention of reduced renal function in HIV infected patients
Jeremy Levy
Jeremy Levy, MA, PhD, DSc(Hon), FHEA, FRCP
Imperial College Healthcare NHS Trust, United Kingdom
15:52 CET
Live Q/A
16:10 CET
Abstract Driven Presentation Session
HIV/AIDS treatment in Elderly Women: Experiences, Unique Challenges, and lessons learned. #O_04
Sendaula Emanuel, Reach Out Mbuya HIV/AIDS Initiative, Uganda
Experiences Engaging in a Group-Based Physiotherapist-Led Exercise Program for Adults Living with HIV and Complex Multimorbidity: A Qualitative Study. #O_06
Alex Ruth, University Of Toronto, Canada
16:22 CET
Live Q&A
16:27 CET
Closing
Jeffrey V. Lazarus, PhD, MIH, MA
Barcelona Institute for Global Health (ISGlobal), Spain and CUNY Graduate School of Public Health and Health Policy, New York
Session 5: PrEP - 16:45
16:45 CET
State of the Art lecture: Maximizing PrEP Use and Retention at the National Level
Julia Del Amo
Julia Del Amo, MD, PhD
Institute of Health Carlos III, Spain
17:01 CET
Long Term Impacts of PrEP – How to reduce toxicity and resistance
Pep Coll, MD
AIDS Research Institute-IrsiCaixa, Spain
17:17 CET
PrEP and new delivery systems: What does the future hold?
Raphael Landovitz, MD, MSc
University of California, Los Angeles, United States
17:32 CET
Live Q/A
17:46 CET
Case Reports: Introduction of PrEP in Challenging Community Settings
17:47 CET
Czech Republic
Zofia Bartovska
Zofia Bartovská, PhD
Military University Hospital Prague
17:57 CET
Poland
Justyna Kowalska
Justyna D. Kowalska, MD, PhD
Medical University of Warsaw
18:08 CET
Update on the Development of the HIV Fourth 90 Consensus Statemen
Jeffrey V. Lazarus, PhD, MIH, MA
Barcelona Institute for Global Health (ISGlobal), Spain and CUNY Graduate School of Public Health and Health Policy, New York
18:18 CET
Live Q/A
18:30 CET
Closing Remarks
Anton Pozniak, MD, FRCP
Chelsea and Westminster Hospital, United Kingdom
Overview
Welcome

"To help the community of future clinical leaders, who embrace an updated and relevant paradigm for the optimal care of HIV infected individuals. Focused not only on viral suppression but also on guaranteeing them optimal health throughout their lifetime. Striving to develop a clinical setting where treatment decisions consider all their implications for long term health."

Over the last two decades, HIV has transformed from a fatal disease into a chronic condition where the great majority of individuals living with HIV can look forward to a full and active life. This is due to an increased understanding of the disease and its management, but, above all, to the unprecedented improvement in antiretroviral drugs.

​Not surprisingly, the current management of individuals living with HIV continues to be overwhelmingly influenced by the fear of AIDS, suffering, and death, with treatment success measured by the long-term avoidance of these conditions. However, in the context of the armamentarium now available to clinicians and individuals living with HIV, much higher goals are attainable. Clinicians should now be focused not only on avoiding AIDS but also on guaranteeing individuals living with HIV a full long life with minimum adverse events or co-morbidities. Planning should not be limited to care over the next 5 – 10 years but for many decades to come, with the expectation of a healthy and productive older age. This requires clinicians to adapt a proactive approach to preventing long-term morbidities and incorporate this into their decision-making process when making treatment choices.

​​We look forward to welcoming you to the next edition of our program and joining our efforts to build a community of HIV treating expert clinicians focusing on promoting a full and healthy life for all patients!

Program Chairs 2020

General Information 

COVID-19 Update
The European Workshop on Healthy Living with HIV 2020 was held as a virtual meeting.

We are available to answer any questions or concerns that you may have about your participation at the European Workshop on Healthy Living with HIV 2020. For more information, please contact Ms. Christina Dammers at christina@amededu.com.

To stay updated on developments about the European Workshop on Healthy Living with HIV, make sure you are signed up for our newsletter.
Meeting Objectives
This meeting aims to:

- Educate HIV clinicians on new treatment options and their long-term implications;

- Increase the HIV clinician’s level of understanding of options for the prevention of comorbidities and adverse events;

- Help shift the clinician’s focus to the management of long-term health;

- Encourage a proactive and protective treatment attitude;

- Broaden the scope of HIV clinicians and enrich their knowledge of and collaboration with other medical disciplines.
Learning Objectives
After participating in this activity, participants will be able to:

• Enhance communication and collaboration between both junior- and senior-level international researchers (from academia, government, and industry) and clinicians to promote the exchange of ideas, results, and technologies leading to successful translation into improving the long term health for HIV-positive individuals;

• Disseminate the knowledge and data exchanged by conference participants beyond the audience of the live event, thus maximizing the impact on the HIV research community.

Practical Information 

Certificate of Attendance
A certificate of attendance was sent to participants that successfully completed the program and post-meeting survey.
Language
The official language of the workshop was English.
Translation was not provided.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The conference secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.
Liability and Insurance
By registering for the workshop, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official workshop sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided that speakers have given permission to do so.
Committees
Chairs 2020
Scientific Committee

The members of Scientific Committee are hand-picked by the Program Chairs based on their significant contributions and commitment to the field. They assist the Program Chairs by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

Support
Founding Father

Gilead Sciences Europe Ltd. has provided funding for this independent Medical Education program. Gilead has had no input into selection of speakers or the content of the materials and presentations.

Endorsers
Language